27 results on '"Bruno, R."'
Search Results
2. Hepatotoxicity and antiretroviral therapy with protease inhibitors: A review
3. Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern Italy
4. Management of hepatitis C in human immunodeficiency virus-infected patients
5. Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients
6. The old patient in DAA era: Real life reports on 5925 patients from the Lombardy HCV Network
7. Treatment of chronic hepatitis C in Lombardia: An analysis on the safety and efficacy of DAA therapy in 5457 patients
8. In-hospital mortality and length of stay in cirrhotic patients with sepsis treated with non-selective beta-blockers
9. Clinical and virological characteristics of HIV and HCV co-infected versus HCV monoinfected patients: A real-life evaluation in the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort
10. Prevalence of hepatitis E in tertiary hospital centre in northern Italy
11. Impact of rifaximin in the prevention of bacterial infections in cirrhosis
12. PRO-inflammatory and pro-fibrogenic actions of the HIV-envelope protein gp120 are mediated by inflammasome activation and MIR29B
13. Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
14. Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
15. F-27 The inflammasome complex is a target of the HIV envelope protein gp120 in human hepatic stellate cells (HSC) and mononuclear cells (MNC)
16. F-45 Rapid virologic response (RVR), IL28B single nucleotide polymorphism (SNP) rs12980275 and HCV genotype are independent predictors of sustained virologic response (SVR) in HIV/HCV coinfected patients treated with pegylated interferon and ribavirin
17. F-42 Gender-specific determinants of response in HCV genotype 1 to current SOC with peg IFN and ribavirin in a practice cohort
18. OC.09.7: PEG-IFN FOR HEPATITIS C IN CLINICAL PRACTICE: RESULTS OF THE RETROSPECTIVE PHASE OF THE AIFA STUDY
19. T-38 PEG-IFN for hepatitis C in clinical practice: Results of the retrospective phase of the AIFA study
20. F-43 A multicenter prospective observational study to evaluate factors influencing efficacy, tolerance and compliance to antiviral tretament with interferon and ribavirin in daily clinical practice
21. T-34 Interleukin-28B polymorphisms, IP-10, viral load and age predict the outcome of therapy in genotype 1 hepatitis C virus under real-life conditions
22. T.N.30 CORRELATION BETWEEN FIB-4, LIVER STIFFNESS AND METABOLIC PARAMETERS IN PATIENTS WITH HIV AND HEPATITIS C VIRUS CO-INFECTION
23. gp120 induces directional migration of human hepatic stellate cells: A link between HIV infection and liver fibrogenesis
24. Results of randomized controlled trial on the impact of prolonged combination anti HCV treatment on relapse rate in HIV/HCV coinfected patients with HCVRNA negativization at the end of a 24–48 weeks course of treatment: The ROMANCE study
25. 4 HIV accelerates occurrence and increases invasiveness of hepatocellular carcinoma (HCC)
26. Antibiotic stewardship and empirical antibiotic treatment: How can they get along?
27. Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.